Cepheid is a molecular diagnostics company that develops, manufactures, and markets integrated systems for testing in the clinical and non-clinical markets. Its systems enable molecular testing for organisms and genetic-based diseases by automating manual laboratory procedures. The Company primarily offers GeneXpert system that integrates sample preparation in addition to DNA amplification and detection. The Company also provides SmartCycler system, which integrates DNA amplification and detection to allow the analysis of a sample, and Xpert tests for use on the GeneXpert system.

Employee Rating

Parent CompanyDanaher
HQSunnyvale, US
Cepheid was founded in 1996 and is headquartered in Sunnyvale, US

Viewing summary data as a guest

Sign up for free to see all data

Cepheid Office Locations

Cepheid has offices in Sunnyvale, Lane Cove West, Wien, Geel and in 11 other locations
Sunnyvale, US (HQ)
904 E Caribbean Dr
Lane Cove West, AU
23-27 Chaplin Drive
Wien, AT
Hernalser Hauptstraße 219
Geel, BE
Kleinhoefstraat 5 bus 26
Maurens-Scopont, FR
Vira Solelh
Frankfurt am Main, DE
Unterlindau 29
Show all (19)

Cepheid Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$27.1 m


Cepheid is a subsidiary of Danaher

Cepheid Revenue

Embed Graph
View revenue for all periods
Cepheid's revenue was reported to be $538.58 m in FY, 2015 which is a 14.6% increase from the previous period.
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015



Revenue growth, %


Cost of goods sold


Gross profit

Show all financial metrics

Cepheid Online and Social Media Presence

Embed Graph

Cepheid News and Updates

Global Molecular Diagnostics Market Analysis, Trends and Forecasts with Profiles of Leading Players Including Abbott Laboratories, bioMrieux SA, Cepheid, Hologic Inc. and Thermo Fischer Scientific Inc.

DUBLIN, May 27, 2020 /PRNewswire/ -- The "Molecular Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis and the looming economic recession, the Molecular Diagnostics market worldwide will grow by a...

Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test

SUNNYVALE, Calif., March 21, 2020 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress SARS-CoV-2, a rapid molecular diagnostic test for qualitative detection of SARS-CoV-2, the virus...

Cepheid Announces FleXible Cartridge Program

SUNNYVALE, Calif., April 15, 2019 /PRNewswire/ -- Cepheid today announced its FleXible Cartridge program to accelerate menu expansion in Europe and China through partnerships with selected Trusted Reagent Manufacturers (TRMs). Through this program, GeneXpert® System users will gain access ...

Strategic Focus Report on Rapid Tests Market 2019-2025: Akers Biosciences, Inc., Alere Inc. (Abbott Laboratories), Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Cepheid Inc., Hologic, Inc.

Rapid testing is a voluntary diagnostic outcome for patients and is recommended for preliminary screening and configuration with limited resources. It increases the incidence of chronic diseases such as diabetes, cardiovascular disease and cancer, increases the awareness of prompt examination due to…

Intelligent Road System Market In-Depth analysis , 2023: Studied in Detail by Focusing on Product Type with Top Companies like Cepheid, Thermo Fischer Scientific, Becton Dickinson

According to the new market research report The research methodology used to estimate and forecast the market begins by capturing the revenues of the key players and their shares in the market. A few organizations associated with the market include Intelligent Transportation Society of America. Calc…

Cepheid Receives CE-IVD Clearance for Xpert® HBV Viral Load

SUNNYVALE, Calif., Dec. 20, 2018 /PRNewswire/ -- Cepheid today announced the CE-IVD marking of Xpert HBV Viral Load, a new rapid test for the quantitation of Hepatitis B Virus (HBV) that delivers results in less than an hour. Xpert HBV Viral Load is intended for use as an indicator of...
Show more

Cepheid Blogs

Cepheid Frequently Asked Questions

  • When was Cepheid founded?

    Cepheid was founded in 1996.

  • What is Cepheid revenue?

    Latest Cepheid annual revenue is $538.6 m.

  • Who are Cepheid competitors?

    Competitors of Cepheid include OncoCell MDx, HEALTH Gene Technologies and Concure Oncology.

  • Where is Cepheid headquarters?

    Cepheid headquarters is located at 904 E Caribbean Dr, Sunnyvale.

  • Where are Cepheid offices?

    Cepheid has offices in Sunnyvale, Lane Cove West, Wien, Geel and in 11 other locations.

  • How many offices does Cepheid have?

    Cepheid has 19 offices.